In addition, several adipogenic surface markers as activating signal cointegrator-1 (ASC-1) and proton-coupled amino acid transporter (PAT2) have been identified to target white and brown adipocytes and fat depots for therapeutic purposes and obesity treatment [7,8]. This evidence concerns the gene TRIP4 and obesity disorder.